What We're Reading: Page 294
Industry reads hand-picked by our editors
Aug 29, 2017
-
Forbes
What can a company justifiably charge for a cancer cure?
-
Bloomberg Businessweek
Medical journals have a fake news problem
-
Reuters
Bristol-Myers, Daiichi Sankyo to test Opdivo combo for cancers
Aug 28, 2017
-
International Business Times
How big pharma secretly funds the fight to keep drug prices high
-
Kaiser Health News
Offshore rush for herpes vaccine roils debate over U.S. safety rules
-
The Guardian
Could a heroin vaccine cure the west’s drug epidemic?
Aug 25, 2017
Aug 24, 2017
-
Kaiser Health News
‘Breakthrough’ leukemia drug also portends ‘quantum leap’ in cost
-
Science
A bold open-access push in Germany could change the future of academic publishing
-
Healthcare Dive
Intermountain plans to cut opioid prescriptions by 40%
-
Regulatory Focus
Patients not always informed of study's purpose in noninferiority trials
Aug 23, 2017
Aug 22, 2017
Aug 21, 2017
-
The Wall Street Journal
How HIV became a cancer cure
-
Financial Times
Hikma hikes price of US medicines by up to 430%
-
Reuters
New Novartis drug takes aim at tough-to-treat malaria
Previous
